SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-034325
Filing Date
2021-02-09
Accepted
2021-02-09 16:09:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d107435d424b5.htm 424B5 401765
2 GRAPHIC g107435g01y88.jpg GRAPHIC 45841
3 GRAPHIC g107435g01z02.jpg GRAPHIC 50680
  Complete submission text file 0001193125-21-034325.txt   520035
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-228831 | Film No.: 21606452
SIC: 2834 Pharmaceutical Preparations